Brandywine Global Investment Management, LLC Revance Therapeutics, Inc. Transaction History
Brandywine Global Investment Management, LLC
- $14.2 Billion
- Q3 2024
A detailed history of Brandywine Global Investment Management, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 283,800 shares of RVNC stock, worth $729,366. This represents 0.01% of its overall portfolio holdings.
Number of Shares
283,800Holding current value
$729,366% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RVNC
# of Institutions
232Shares Held
82.1MCall Options Held
680KPut Options Held
896K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.73MShares$14.7 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.78MShares$12.3 Million0.0% of portfolio
-
Fil LTD Hamilton, D04.19MShares$10.8 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ4.16MShares$10.7 Million0.49% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...